News
Thursday, July 4th, 2019
Sirona Biochem Releases CEO Letter to Shareholders
Wednesday, July 3rd, 2019
Sirona Biochem Announces SGLT2 Inhibitor Development Progress
Thursday, June 20th, 2019
Sirona Biochem Reports 2019 AGM Voting and CEO Update
Wednesday, June 19th, 2019
Sirona Biochem Signs Term Sheet for TFC-1067 with Skincare Industry Leader Rodan + Fields
Monday, June 17th, 2019
Sirona Biochem Announces TFC-1067 Skin Lightening Patent Granted in USA
Wednesday, June 12th, 2019
Sirona Biochem Appoints Chinese Lawyer Jason Tian To Its Board of Directors
Tuesday, June 11th, 2019
Sirona Biochem Reports Approval to Test Higher Concentrations of Skin Lightening Compound TFC-1067
Tuesday, May 28th, 2019
Sirona Biochem Reports Excellent Preliminary Safety Assessment of Lead Anti-Wrinkle Compound LIP-01
Wednesday, May 22nd, 2019
Sirona Biochem Hires Contract Research Organization for Manufacturing Process Optimization for TFC-1067
Wednesday, May 15th, 2019
Sirona Biochem Receives Positive Clinical Results of its Skin Lightening Compound TFC-1067 from China
Product Development
While carbohydrate-based molecules offer immense commercial potential, we are focusing on three programs at this time.
Social Links Sidebar